A compact, low-cost, quantitative and multiplexed fluorescence detection platform for point-of-care applications

Biosens Bioelectron. 2018 Oct 15:117:153-160. doi: 10.1016/j.bios.2018.04.002. Epub 2018 Apr 4.

Abstract

An effective method of combating infectious diseases is the deployment of hand-held devices at the point-of-care (POC) for screening or self-monitoring applications. There is a need for very sensitive, low-cost and quantitative diagnostic devices. In this study, we present a low-cost, multiplexed fluorescence detection platform that has a high sensitivity and wide dynamic range. Our system features inexpensive 3 × 3 mm interference filters with a high stopband rejection, sharp transition edges, and greater than 90% transmission in the passband. In addition to the filters, we improve signal-to-noise ratio by leveraging time for accuracy using a charge-integration-based readout. The fluorescence sensing platform provides a sensitivity to photon flux of ∼1×104photons/mm2sec and has the potential for 2-3 orders of magnitude improvement in sensitivity over standard colorimetric detection that uses colored latex microspheres. We also detail the design, development, and characterization of our low-cost fluorescence detection platform and demonstrate 100% and 97.96% reduction in crosstalk probability and filter cost, respectively. This is achieved by reducing filter dimensions and ensuring appropriate channel isolation in a 2 × 2 array configuration. Practical considerations with low-cost interference filter system design, analysis, and system performance are also discussed. The performance of our platform is compared to that of a standard laboratory array scanner. We also demonstrate the detection of antibodies to human papillomavirus (HPV16) E7 protein, as a potential biomarker for early cervical cancer detection in human plasma.

Keywords: Colorimetry; Diagnostics; Fluorescence; Limit of detection; Multiplexed; Point-of-care.

MeSH terms

  • Antibodies / blood*
  • Biomarkers / blood
  • Biosensing Techniques / instrumentation*
  • Biosensing Techniques / methods*
  • Colorimetry / standards
  • Early Detection of Cancer / instrumentation*
  • Early Detection of Cancer / methods*
  • Female
  • Humans
  • Papillomavirus E7 Proteins / immunology
  • Point-of-Care Systems
  • Uterine Cervical Neoplasms / diagnosis*

Substances

  • Antibodies
  • Biomarkers
  • Papillomavirus E7 Proteins
  • oncogene protein E7, Human papillomavirus type 16